1. Home
  2. ABVX vs HOMB Comparison

ABVX vs HOMB Comparison

Compare ABVX & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • HOMB
  • Stock Information
  • Founded
  • ABVX 2013
  • HOMB 1998
  • Country
  • ABVX France
  • HOMB United States
  • Employees
  • ABVX N/A
  • HOMB N/A
  • Industry
  • ABVX
  • HOMB Major Banks
  • Sector
  • ABVX
  • HOMB Finance
  • Exchange
  • ABVX Nasdaq
  • HOMB Nasdaq
  • Market Cap
  • ABVX 5.3B
  • HOMB 5.8B
  • IPO Year
  • ABVX N/A
  • HOMB 2006
  • Fundamental
  • Price
  • ABVX $70.44
  • HOMB $28.22
  • Analyst Decision
  • ABVX Buy
  • HOMB Hold
  • Analyst Count
  • ABVX 7
  • HOMB 5
  • Target Price
  • ABVX $74.86
  • HOMB $31.80
  • AVG Volume (30 Days)
  • ABVX 3.2M
  • HOMB 903.7K
  • Earning Date
  • ABVX 08-11-2025
  • HOMB 07-16-2025
  • Dividend Yield
  • ABVX N/A
  • HOMB 2.83%
  • EPS Growth
  • ABVX N/A
  • HOMB 14.00
  • EPS
  • ABVX N/A
  • HOMB 2.19
  • Revenue
  • ABVX $11,444,012.00
  • HOMB $1,007,568,000.00
  • Revenue This Year
  • ABVX N/A
  • HOMB $12.79
  • Revenue Next Year
  • ABVX $41.36
  • HOMB $2.65
  • P/E Ratio
  • ABVX N/A
  • HOMB $12.91
  • Revenue Growth
  • ABVX 128.98
  • HOMB 3.66
  • 52 Week Low
  • ABVX $4.77
  • HOMB $24.22
  • 52 Week High
  • ABVX $75.51
  • HOMB $32.91
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 80.00
  • HOMB 46.89
  • Support Level
  • ABVX $68.26
  • HOMB $27.48
  • Resistance Level
  • ABVX $73.90
  • HOMB $28.04
  • Average True Range (ATR)
  • ABVX 3.64
  • HOMB 0.52
  • MACD
  • ABVX -1.64
  • HOMB 0.05
  • Stochastic Oscillator
  • ABVX 46.06
  • HOMB 50.75

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About HOMB Home BancShares Inc.

Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.

Share on Social Networks: